Shmuel Ben Zvi
Director/Board Member at BANK LEUMI LE-ISRAEL B.M.
Net worth: - $ as of 30/03/2024
Profile
Shmuel Ben Zvi is an Independent Director at Bank Leumi Le-Israel B.M.
since 2015 and at Protalix Biotherapeutics, Inc. since 2022.
He is also the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
Dr. Ben Zvi previously served as the Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd.
from 2004 to 2014.
He was an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2018 to 2023.
Additionally, he held the position of Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Dr. Ben Zvi has an educational background from Tel-Aviv University, where he obtained undergraduate, graduate, and doctorate degrees.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/09/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Shmuel Ben Zvi active positions
| Companies | Position | Start |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Director/Board Member | 28/07/2015 |
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 29/06/2022 |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
Former positions of Shmuel Ben Zvi
| Companies | Position | End |
|---|---|---|
| NOTABLE LABS, LTD. | Director/Board Member | 15/10/2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 30/11/2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 31/12/2003 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Training of Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
- Stock Market
- Insiders
- Shmuel Ben Zvi
